
Pharmacists are much more likely to see prescriptions for sodium-glucose co-transporter 2 (SGLT2) inhibitors than obesity medications, recent prescription data reveal.

Pharmacists are much more likely to see prescriptions for sodium-glucose co-transporter 2 (SGLT2) inhibitors than obesity medications, recent prescription data reveal.

Recently, researchers identified 5 predictive factors for weight loss extent in overweight patients with type 2 diabetes.

In addition to weight gain and poor diet quality, eating meals outside the home has been linked with a greater risk of developing type 2 diabetes.

Obese patients who are able to lose 5% of their bodyweight may lower their risk for type 2 diabetes.



From sedentary desk jobs to antipsychotics, the causes of weight gain are unique to each patient. Working together, pharmacists and patients can create a tailored weight loss plan that addresses individual goals and challenges.